drugset / Trial / NCT01646853

Radiation Dose Study of Concurrent Chemoradiotherapy With Cisplatin Plus Fluorouracil in Oesophageal Cancer

NCT01646853

Unknown 500 enrolled Simcere Pharmaceutical Co., Ltd
NaSingle-groupTreatment

Summary

The objective of this study is to determine the optimal radiation dosage used in concurrent chemo-radiotherapy in Chinese population. A dose climbing experiment is carried out with an initiate dose of 50Gy conventionally applied in Western countries.

Timeline

Start
2012-08
Primary completion
2013-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Cisplatin Other / unclassified 75 mg/m2
Background fluorouracil Small molecule 1000 mg/m2 Intravenous

Indications